Literature DB >> 21610031

Transient expression of Mnb/Dyrk1a couples cell cycle exit and differentiation of neuronal precursors by inducing p27KIP1 expression and suppressing NOTCH signaling.

Barbara Hämmerle1, Edgar Ulin, Jordi Guimera, Walter Becker, François Guillemot, Francisco J Tejedor.   

Abstract

The decision of a neural precursor to stop dividing and begin its terminal differentiation at the correct place, and at the right time, is a crucial step in the generation of cell diversity in the nervous system. Here, we show that the Down's syndrome candidate gene (Mnb/Dyrk1a) is transiently expressed in prospective neurons of vertebrate CNS neuroepithelia. The gain of function (GoF) of Mnb/Dyrk1a induced proliferation arrest. Conversely, its loss of function (LoF) caused over proliferation and cell death. We found that MNB/DYRK1A is both necessary and sufficient to upregulate, at transcriptional level, the expression of the cyclin-dependent kinase inhibitor p27(KIP1) in the embryonic chick spinal cord and mouse telencephalon, supporting a regulatory role for MNB/DYRK1A in cell cycle exit of vertebrate CNS neurons. All these actions required the kinase activity of MNB/DYRK1A. We also observed that MNB/DYRK1A is co-expressed with the NOTCH ligand Delta1 in single neuronal precursors. Furthermore, we found that MNB/DYRK1A suppressed NOTCH signaling, counteracted the pro-proliferative action of the NOTCH intracellular domain (NICD), stimulated Delta1 expression and was required for the neuronal differentiation induced by the decrease in NOTCH signaling. Nevertheless, although Mnb/Dyrk1a GoF led to extensive withdrawal of neuronal precursors from the cell cycle, it was insufficient to elicit their differentiation. Remarkably, a transient (ON/OFF) Mnb/Dyrk1a GoF efficiently induced neuronal differentiation. We propose that the transient expression of MNB/DYRK1A in neuronal precursors acts as a binary switch, coupling the end of proliferation and the initiation of neuronal differentiation by upregulating p27KIP1 expression and suppressing NOTCH signaling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21610031      PMCID: PMC3100710          DOI: 10.1242/dev.066167

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  87 in total

Review 1.  CDK inhibitors: positive and negative regulators of G1-phase progression.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1999-06-15       Impact factor: 11.361

2.  Altered patterns of neuron production in the p27 knockout mouse.

Authors:  Tomohide Goto; Takayuki Mitsuhashi; Takao Takahashi
Journal:  Dev Neurosci       Date:  2004 Mar-Aug       Impact factor: 2.984

Review 3.  Notch signalling and the control of cell fate choices in vertebrates.

Authors:  J Lewis
Journal:  Semin Cell Dev Biol       Date:  1998-12       Impact factor: 7.727

4.  Human minibrain homologue (MNBH/DYRK1): characterization, alternative splicing, differential tissue expression, and overexpression in Down syndrome.

Authors:  J Guimera; C Casas; X Estivill; M Pritchard
Journal:  Genomics       Date:  1999-05-01       Impact factor: 5.736

5.  Kinetic properties of a MNB/DYRK1A mutant suitable for the elucidation of biochemical pathways.

Authors:  Tatyana Adayev; Mo-Chou Chen-Hwang; Noriko Murakami; Jerzy Wegiel; Yu-Wen Hwang
Journal:  Biochemistry       Date:  2006-10-03       Impact factor: 3.162

6.  A cell-autonomous requirement for Cip/Kip cyclin-kinase inhibitors in regulating neuronal cell cycle exit but not differentiation in the developing spinal cord.

Authors:  Hongxing Gui; Shike Li; Michael P Matise
Journal:  Dev Biol       Date:  2006-10-27       Impact factor: 3.582

7.  The on/off of Pax6 controls the tempo of neuronal differentiation in the developing spinal cord.

Authors:  Sophie Bel-Vialar; François Medevielle; Fabienne Pituello
Journal:  Dev Biol       Date:  2007-02-16       Impact factor: 3.582

Review 8.  Coupling cell cycle exit, neuronal differentiation and migration in cortical neurogenesis.

Authors:  Laurent Nguyen; Arnaud Besson; James M Roberts; François Guillemot
Journal:  Cell Cycle       Date:  2006-10-16       Impact factor: 4.534

9.  p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex.

Authors:  Laurent Nguyen; Arnaud Besson; Julian Ik-Tsen Heng; Carol Schuurmans; Lydia Teboul; Carlos Parras; Anna Philpott; James M Roberts; François Guillemot
Journal:  Genes Dev       Date:  2006-05-16       Impact factor: 11.361

Review 10.  DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A): a gene with dosage effect during development and neurogenesis.

Authors:  M Dierssen; M Martínez de Lagrán
Journal:  ScientificWorldJournal       Date:  2006-06-17
View more
  51 in total

Review 1.  Down syndrome: the brain in trisomic mode.

Authors:  Mara Dierssen
Journal:  Nat Rev Neurosci       Date:  2012-12       Impact factor: 34.870

2.  Tumorigenesis in Down's syndrome: big lessons from a small chromosome.

Authors:  Dean Nižetić; Jürgen Groet
Journal:  Nat Rev Cancer       Date:  2012-09-21       Impact factor: 60.716

3.  DYRK1A interacts with histone acetyl transferase p300 and CBP and localizes to enhancers.

Authors:  Shanshan Li; Chu Xu; Yinkun Fu; Pin-Ji Lei; Yanhua Yao; Wanli Yang; Ying Zhang; Michael P Washburn; Laurence Florens; Manish Jaiswal; Min Wu; Man Mohan
Journal:  Nucleic Acids Res       Date:  2018-11-30       Impact factor: 16.971

4.  Proline Hydroxylation Primes Protein Kinases for Autophosphorylation and Activation.

Authors:  Sang Bae Lee; Aram Ko; Young Taek Oh; Peiguo Shi; Fulvio D'Angelo; Brulinda Frangaj; Antonius Koller; Emily I Chen; Timothy Cardozo; Antonio Iavarone; Anna Lasorella
Journal:  Mol Cell       Date:  2020-07-07       Impact factor: 17.970

5.  OLIG2 over-expression impairs proliferation of human Down syndrome neural progenitors.

Authors:  Jie Lu; Gewei Lian; Hui Zhou; Giuseppe Esposito; Luca Steardo; Laurent C Delli-Bovi; Jonathan L Hecht; Q Richard Lu; Volney Sheen
Journal:  Hum Mol Genet       Date:  2012-02-17       Impact factor: 6.150

6.  Ten new cases further delineate the syndromic intellectual disability phenotype caused by mutations in DYRK1A.

Authors:  Lucas M Bronicki; Claire Redin; Severine Drunat; Amélie Piton; Michael Lyons; Sandrine Passemard; Clarisse Baumann; Laurence Faivre; Julien Thevenon; Jean-Baptiste Rivière; Bertrand Isidor; Grace Gan; Christine Francannet; Marjolaine Willems; Murat Gunel; Julie R Jones; Joseph G Gleeson; Jean-Louis Mandel; Roger E Stevenson; Michael J Friez; Arthur S Aylsworth
Journal:  Eur J Hum Genet       Date:  2015-04-29       Impact factor: 4.246

7.  Genetic dissection of the Down syndrome critical region.

Authors:  Xiaoling Jiang; Chunhong Liu; Tao Yu; Li Zhang; Kai Meng; Zhuo Xing; Pavel V Belichenko; Alexander M Kleschevnikov; Annie Pao; Jennifer Peresie; Sarah Wie; William C Mobley; Y Eugene Yu
Journal:  Hum Mol Genet       Date:  2015-09-15       Impact factor: 6.150

Review 8.  Genetic and epigenetic pathways in Down syndrome: Insights to the brain and immune system from humans and mouse models.

Authors:  Y Eugene Yu; Zhuo Xing; Catherine Do; Annie Pao; Eun Joon Lee; Sharon Krinsky-McHale; Wayne Silverman; Nicole Schupf; Benjamin Tycko
Journal:  Prog Brain Res       Date:  2019-10-24       Impact factor: 2.453

9.  Human chromosome 21 orthologous region on mouse chromosome 17 is a major determinant of Down syndrome-related developmental cognitive deficits.

Authors:  Li Zhang; Kai Meng; Xiaoling Jiang; Chunhong Liu; Annie Pao; Pavel V Belichenko; Alexander M Kleschevnikov; Sheena Josselyn; Ping Liang; Ping Ye; William C Mobley; Y Eugene Yu
Journal:  Hum Mol Genet       Date:  2013-09-16       Impact factor: 6.150

10.  Dyrk1a haploinsufficiency induces diabetes in mice through decreased pancreatic beta cell mass.

Authors:  Latif Rachdi; Dulanjalee Kariyawasam; Fanny Guez; Virginie Aïello; Maria L Arbonés; Nathalie Janel; Jean-Maurice Delabar; Michel Polak; Raphaël Scharfmann
Journal:  Diabetologia       Date:  2014-01-30       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.